Compare Elevance Health Inc. Common Stock (ELV) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elevance Health Inc. Common Stock vs Inovio Pharmaceuticals Inc — how do they compare? Elevance Health Inc. Common Stock trades at $411.65 (market cap $86.95B), while Inovio Pharmaceuticals Inc trades at $1.15 (market cap $112.19M). The key difference: Elevance Health Inc. Common Stock is far larger — about 775× Inovio Pharmaceuticals Inc's market cap, and Elevance Health Inc. Common Stock pays a 1.72% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ELV | INO | |
|---|---|---|
Market Cap | $86.95B | $112.19M |
Volume | 782,706 | 3,201,278 |
Sector | Health | Health |
52-Week High | $426.79 | $2.65 |
52-Week Low | $280.74 | $0.66 |
Enterprise Value | $107.76B | $83.51M |
Dividend Yield | 1.72% | — |
Typical Hold Time | — | 43 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO trades at $1.15, down 0.43% on the day, with a bearish technical signal from moving averages and oscillators. The company shows consistent quarterly earnings beats but operates at significant losses with a -130,000% net income margin and negative cash flow. Key catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107, with analyst consensus leaning bullish at a $2.75 price target.
The investment case hinges on FDA approval of INO-3107, offering substantial upside from current levels. However, persistent cash burn, minimal revenue, and high valuation multiples relative to sales pose significant risks. Investors face binary outcomes driven by regulatory decisions and commercialization execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
